Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  The Yield Growth Corp.    BOSS   CA98584W2067


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

This May be the Trick to Treating a Massive $16 Billion Weight Issue

share with twitter share with LinkedIn share with facebook
07/02/2020 | 07:45am EDT

Houston, Texas--(Newsfile Corp. - July 2, 2020) - The obesity issue is bursting at the seams.

In fact, according to the World Health Organization, at least 2.8 million people die every year from being either overweight or obese.

Worse, such issues lead to chronic diseases, including cardiovascular diseases (mainly heart disease and stroke), diabetes, musculoskeletal disorders (especially osteoarthritis - a highly disabling degenerative disease of the joints); and some cancers (including endometrial, breast, ovarian, prostate, liver, gallbladder, kidney, and colon).

On top of that, it costs the world up to $64 billion a year to treat cardiovascular events. It costs another $87 billion to treat diabetes worldwide. Worse, it costs the world $16 billion a year to help treat obesity.

However, the world may soon get the solution it needs to help treat such issues, stemming from being obese or overweight with psilocybin.

That's because psilocybin activates serotonin receptors, or "nature's own appetite suppressant," as noted by Psychology Today. "This powerful brain chemical curbs cravings and shuts off appetite. It makes you feel satisfied even if your stomach is not full. The result is eating less and losing weight."

Researching the issue is Yield Growth's majority owned subsidiary NeonMind.

In fact, the company just filed a U.S. provisional patent application in the United States for the invention relating to therapeutic administration of psilocybin or psilocin (or analogs thereof) combined with supportive therapeutic treatment for a patient to provide weight loss benefits and treatment for related health issues.

It did so to protect the invention that the administration of psilocin or psilocybin results in overall weight loss in individuals by:

  • reducing food cravings;
  • counteracting compulsive overeating; and
  • improving quality of diet by empowering the mind to select lower calorie foods with greater nutritional value.

The pending patent also covers the use of micro dose administration of psilocin or psilocybin or both compounds to have the additional weight loss effects of:

  • increasing metabolism,
  • treating or regulating diabetes,
  • regulating blood glucose, and
  • reducing susceptibility to cardiovascular disease, high blood pressure, diabetes mellitus and other illnesses associated with obesity.

In addition, the company engaged TLS, which is a contract research organization, to conduct analytical testing and pre-clinical/clinical testing and obtain Health Canada approval for its planned clinical trials.

For more information, visit the company's website at https://yieldgrowth.com.

About MarijuanaStox

MarijuanaStox.com is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news. MarijuanaStox.com is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of MarijuanaStox.com) and The Yield Growth Corp, Winning Media has been paid four thousand dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer.

Contact Information:

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59033

© Newsfilecorp 2020
share with twitter share with LinkedIn share with facebook
08/07YIELD GROWTH CORP : . - NeonMind Submits Application for Psilocybin Research to ..
08/06NeonMind Submits Application for Psilocybin Research to Health Canada
08/05Plant-Based Products Are Quickly Disrupting $4.2 Trillion Wellness Market
08/05YIELD GROWTH : Appoints Spiros Margaris as Audit Committee Chair and appoints Di..
07/30Yield Growth Closes $1.4 Million Financing
07/22Yield Growth Launches Shopify Online Store to Bolster Direct to Consumer Sale..
07/16Yield Growth's Plant-Based Products List for Sale on Amazon
07/15Plant-Based Product Revolution is Creating a Potential $20.8 Billion Opportun..
07/14Yield Growth's Plant-Based Products and Hand Sanitizers to be Sold in Pharmas..
07/09Yield Growth Announces Manufacturing of Plant-Based Deodorant
More news
Sales 2019 4,02 M 3,02 M 3,02 M
Net income 2019 -16,0 M -12,0 M -12,0 M
Net cash 2019 0,54 M 0,40 M 0,40 M
P/E ratio 2019 -1,43x
Yield 2019 -
Capitalization 13,6 M 10,2 M 10,2 M
EV / Sales 2018 -
EV / Sales 2019 6,43x
Nbr of Employees 19
Free-Float 67,0%
Duration : Period :
The Yield Growth Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE YIELD GROWTH CORP.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 1
Average target price 0,45 CAD
Last Close Price 0,10 CAD
Spread / Highest target 374%
Spread / Average Target 374%
Spread / Lowest Target 374%
EPS Revisions
Penny White President, Chief Executive Officer & Director
Tamara Melck Chief Operating Officer
Yu Cai Huang Chief Financial Officer
Spiros Margaris Independent Director
Cole Drezdoff Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON1.87%389 737
ROCHE HOLDING AG-0.11%293 027
PFIZER, INC.-2.02%213 329
MERCK & CO., INC.-11.04%204 641
NOVARTIS AG-17.86%181 730